Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Oseltamivir/therapeutic use"'
Publikováno v:
Critical Care, Vol 22, Iss 1, Pp 1-3 (2018)
Critical care, vol. 22, no. 1, pp. 332
Critical Care
Critical care, vol. 22, no. 1, pp. 332
Critical Care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d839b885361129c570baeb4703861453
http://link.springer.com/article/10.1186/s13054-018-2263-y
http://link.springer.com/article/10.1186/s13054-018-2263-y
Autor:
Nickolaj R. Kristensen, Brigitta Monz, Henrik Toft Sørensen, Barry Clinch, A. Kenwright, Vera Ehrenstein
Publikováno v:
BMC Infectious Diseases
Ehrenstein, V, Kristensen, N R, Monz, B U, Clinch, B, Kenwright, A & Sørensen, H T 2018, ' Oseltamivir in pregnancy and birth outcomes ', BMC Infectious Diseases, vol. 18, no. 1, pp. 519 . https://doi.org/10.1186/s12879-018-3423-z
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-10 (2018)
Ehrenstein, V, Kristensen, N R, Monz, B U, Clinch, B, Kenwright, A & Sørensen, H T 2018, ' Oseltamivir in pregnancy and birth outcomes ', BMC Infectious Diseases, vol. 18, no. 1, pp. 519 . https://doi.org/10.1186/s12879-018-3423-z
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-10 (2018)
Background Prenatal exposure to influenza or fever is associated with risk of congenital malformations. Oseltamivir is used to treat influenza and to provide post-exposure prophylaxis. We examined the association between oseltamivir use during pregna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0fa8da88577b250030e443499bf4159
http://europepmc.org/articles/PMC6192366
http://europepmc.org/articles/PMC6192366
Autor:
Noémie Wagner, Klara M. Posfay-Barbe, Laurent Kaiser, Arnaud G L'Huillier, Claire-Anne Siegrist, Pierre-Alex Crisinel, Cristina Delcò, Jean Taguebue, Constance Barazzone
Publikováno v:
European Journal of Pediatrics, Vol. 171, No 1 (2012) pp. 159-66
The true burden of influenza in children is difficult to assess and is probably underestimated as clinical signs are usually nonspecific, and formal viral identification is rarely searched. In this study, we compare the clinical features of infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::976496d5d005e5cc7d94ea875ccf003e
http://doc.rero.ch/record/317220/files/431_2011_Article_1513.pdf
http://doc.rero.ch/record/317220/files/431_2011_Article_1513.pdf
Publikováno v:
Journal of Medical Virology, Vol. 89, No 4 (2017) pp. 737-741
The H275Y and E119D neuraminidase (NA) mutations constitute important molecular markers of resistance to NA inhibitors in A(H1N1) pdm09 viruses. We used reverse transcriptase-droplet digital PCR amplification (RT-ddPCR) to analyze quasi-species at co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5733618fb6e31a66e7619efe4be8f5ea
https://pubmed.ncbi.nlm.nih.gov/27602879
https://pubmed.ncbi.nlm.nih.gov/27602879
Autor:
Laurent Kaiser, Yves Chalandon, Yves Thomas, M Nagy, Eddy Roosnek, Jakob Passweg, Emmanuel Levrat, Bilal Mohty, Marija Vukicevic, Michael Bernimoulin
Publikováno v:
Bone Marrow Transplantation, Vol. 47, No 2 (2012) pp. 236-42
Bone marrow transplantation
Bone Marrow Transplantation
Bone marrow transplantation
Bone Marrow Transplantation
The impact of the 2009 H1N1 Influenza A (H1N1) pandemic in allogeneic hematopoietic SCT recipients (allo HSCT) is not yet well defined. Between May 2009 and May 2010 all allo HSCTs who presented with respiratory symptoms were screened for the presenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c94cfb8af4f7d77fd8c9dc729b508bcf
https://archive-ouverte.unige.ch/unige:25421
https://archive-ouverte.unige.ch/unige:25421
Autor:
Fabrice, Carrat, Xavier, Duval, Florence, Tubach, Anne, Mosnier, Sylvie, Van der Werf, Annick, Tibi, Thierry, Blanchon, Catherine, Leport, Antoine, Flahault, France, Mentré, V, Zeline
Publikováno v:
Antiviral Therapy, Vol. 17, No 6 (2012) pp. 1085-90
Background The effectiveness of neuraminidase inhibitors to reduce transmission when used as treatment in influenza-infected patients remains debated. Methods In a prespecified analysis of a blinded randomized controlled trial on the efficacy of osel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf468346e1082ab76bfa810390d60278
https://pubmed.ncbi.nlm.nih.gov/22910171
https://pubmed.ncbi.nlm.nih.gov/22910171
Autor:
Sophia Ng, Kwok H. Chan, Dennis K. M. Ip, Peter M. Houck, Vicky J. Fang, J. S. Malik Peiris, Benjamin J. Cowling, Gabriel M. Leung, Timothy M. Uyeki, Calvin K. Y. Cheng
Publikováno v:
Clinical Infectious Diseases
Background. Large clinical trials have demonstrated the therapeutic efficacy of oseltamivir against influenza. We assessed the indirect effectiveness of oseltamivir in reducing secondary household transmission in an incident cohort of influenza index
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf935811e932ed77e45e173e8db49462
http://hdl.handle.net/10722/86785
http://hdl.handle.net/10722/86785
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.